文献速递肝病消化道肿瘤与早癌

肠道微生物组在肝胆癌发生中的作用

The role of the gut microbiome in the development of hepatobiliary cancers.
PubMed 文献 · Hepatology · 2023-04-15

肝胆癌死亡率高且发病率上升,与不健康西方饮食生活方式及肥胖相关。综述肠道微生物组通过「肠-肝轴」参与肝胆癌发生的实验与观察证据,涉及菌群失调、肠屏障功能下降、炎症化合物暴露及代谢功能障碍,并概述饮食生活方式影响、新兴微生物组编辑技术及潜在治疗与预防策略。

要点

  • 肠道微生物组与肝脏通过「肠-肝轴」双向交互,参与肝胆癌发生。
  • 菌群失调、肠屏障功能下降、炎症化合物暴露及代谢功能障碍是contributors。
  • 饮食生活方式经肠道微生物组介导影响肝脏病理,新兴编辑技术正在研究中。

核心结论

  • 肠道微生物组通过「肠-肝轴」参与肝胆癌发生,新兴机制见解正为治疗和预防策略提供信息。

研究设计与样本

  • 综述,概述肠道微生物组失调、肠屏障功能下降、炎症化合物暴露及代谢功能障碍在肝胆癌发生中的实验与观察证据。

主要发现

  • 肠道微生物组与肝脏通过「肠-肝轴」双向交互。
  • 菌群失调、肠屏障功能下降、炎症化合物暴露及代谢功能障碍被视为肝胆癌发生的contributors。
  • 饮食和生活方式因素经肠道微生物组介导影响肝脏病理。
  • 多种新兴肠道微生物组编辑技术正在肝胆疾病背景下被研究。

临床怎么用

  • 作者指出,新兴机制见解正为治疗提供信息,如潜在的微生物群操纵策略,并指导关于饮食/生活方式模式的公共卫生建议以预防这些致命肿瘤。

局限性

  • 原文指出,在确定肠道微生物组与肝胆癌之间关系方面仍有大量工作要做。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatobiliary cancers, including hepatocellular carcinoma and cancers of the biliary tract, share high mortality and rising incidence rates. They may also share several risk factors related to unhealthy western-type dietary and lifestyle patterns as well as increasing body weights and rates of obesity. Recent data also suggest a role for the gut microbiome in the development of hepatobiliary cancer and other liver pathologies. The gut microbiome and the liver interact bidirectionally through the "gut-liver axis," which describes the interactive relationship between the gut, its microbiota, and the liver. Here, we review the gut-liver interactions within the context of hepatobiliary carcinogenesis by outlining the experimental and observational evidence for the roles of gut microbiome dysbiosis, reduced gut barrier function, and exposure to inflammatory compounds as well as metabolic dysfunction as contributors to hepatobiliary cancer development. We also outline the latest findings regarding the impact of dietary and lifestyle factors on liver pathologies as mediated by the gut microbiome. Finally, we highlight some emerging gut microbiome editing techniques currently being investigated in the context of hepatobiliary diseases. Although much work remains to be done in determining the relationships between the gut microbiome and hepatobiliary cancers, emerging mechanistic insights are informing treatments, such as potential microbiota manipulation strategies and guiding public health advice on dietary/lifestyle patterns for the prevention of these lethal tumors.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Daniel N, Genua F, Jenab M, et al. The role of the gut microbiome in the development of hepatobiliary cancers. Hepatology. 2023. PMID: 37055022. doi:10.1097/HEP.0000000000000406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。